Paris A. Kosmidis
Hygeia Hospital
Tsoha 2 and Vas. Sofias Ave
11521
Athens
Greece
Name/email consistency: high
- Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2. Kosmidis, P.A., Syrigos, K., Kalofonos, H.P., Dimopoulos, M.A., Skarlos, D., Pavlidis, N., Boukovinas, I., Bafaloukos, D., Pectasides, D., Bacoyiannis, C., Fountzilas, G. Anticancer Res. (2012)
- Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG). Kosmidis, P.A., Fountzilas, G., Eleftheraki, A.G., Kalofonos, H.P., Pentheroudakis, G., Skarlos, D., Dimopoulos, M.A., Bafaloukos, D., Pectasides, D., Samantas, E., Boukovinas, J., Lambaki, S., Katirtzoglou, N., Bakogiannis, C., Syrigos, K.N. Ann. Oncol. (2011)
- Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group. Kosmidis, P.A., Kalofonos, H.P., Christodoulou, C., Syrigos, K., Makatsoris, T., Skarlos, D., Bakogiannis, C., Nicolaides, C., Bafaloukos, D., Bamias, A., Samantas, E., Xiros, N., Boukovinas, I., Fountzilas, G., Dimopoulos, M.A. Ann. Oncol. (2008)
- Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group. Kosmidis, P.A., Dimopoulos, M.A., Syrigos, K., Nicolaides, C., Aravantinos, G., Boukovinas, I., Pectasides, D., Fountzilas, G., Bafaloukos, D., Bacoyiannis, C., Kalofonos, H.P. J. Thorac. Oncol (2007)
- Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study. Kosmidis, P., Fountzilas, G., Baka, S., Samantas, E., Dimopoulos, A.M., Gogas, H., Skarlos, D., Papacostas, P., Boukovinas, J., Bakogiannis, C., Pantelakos, P., Athanasiou, H., Misailidou, D., Tsekeris, P., Pavlidis, N. Anticancer Res. (2007)
- Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?. Kosmidis, P., Krzakowski, M. Lung. Cancer (2005)
- Treatment of carcinoid of the lung. Kosmidis, P.A. Curr. Opin. Oncol (2004)
- Advanced NSCLC: new cytostatic agents. Kosmidis, P.A., Manegold, C. Lung. Cancer (2003)
- Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. Kosmidis, P., Mylonakis, N., Nicolaides, C., Kalophonos, C., Samantas, E., Boukovinas, J., Fountzilas, G., Skarlos, D., Economopoulos, T., Tsavdaridis, D., Papakostas, P., Bacoyiannis, C., Dimopoulos, M. J. Clin. Oncol. (2002)
- Chemotherapy in NSCLC: historical review. Kosmidis, P. Lung. Cancer (2002)
- Interim results of a phase III trial. Paclitaxel/carboplatin vs paclitaxel/gemcitabine in advanced non-small-cell lung cancer. Kosmidis, P. Oncology (Williston Park, N.Y.) (2000)
- Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG). Kosmidis, P., Mylonakis, N., Skarlos, D., Samantas, E., Dimopoulos, M., Papadimitriou, C., Kalophonos, C., Pavlidis, N., Nikolaidis, C., Papaconstantinou, C., Fountzilas, G. Ann. Oncol. (2000)
